Sientra, Inc.

Equities

SIEN

US82621J2042

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 20:56:24 17/05/2024 BST			5-day change	1st Jan Change
0.035 ^USD	-50.00%		+16.67%	-94.26%

04-24	Tiger Aesthetics Medical, LLC acquired Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q).	CI
04-15	Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	CI

Sientra, Inc. Appoints Andy Schmidt as Chief Financial Officer

July 12, 2021 at 01:00 pm

Sientra, Inc. announced that Andy Schmidt has been appointed Chief Financial Officer effective July 12, 2021. As a key member of the company's executive leadership team, Mr. Schmidt will lead the Company’s financial operations.

Latest news about Sientra, Inc.

Tiger Aesthetics Medical, LLC acquired Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q).	04-23	CI
Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	04-15	CI
North American Morning Briefing : Stock Futures -2-	04-11	DJ
North American Morning Briefing : Focus Turns to -2-	04-04	DJ
Tiger Aesthetics Medical, LLC agreed to acquire Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q) for $42.5 million.	04-01	CI
Motion for Asset Sale Filed by Sientra, Inc.	04-01	CI
Final DIP Financing Approved for Sientra, Inc.	03-11	CI
Bidding Procedure Approved for Sientra, Inc.	03-05	CI
Sientra, Inc.(OTCPK:SIEN.Q) dropped from NASDAQ Composite Index	02-20	CI
Sientra, Inc.(NasdaqGS:SIEN) dropped from S&P TMI Index	02-15	CI
Interim DIP Financing Approved for Sientra, Inc.	02-14	CI
Motion for Joint Administration Approved for Sientra, Inc.	02-14	CI
Health Care Limits Losses Amid Defensive Bias -- Health Care Roundup	02-13	DJ
Sientra Shares Plunge After Company Seeks Sale of Business, Files for Bankruptcy	02-13	MT
Motion for Asset Sale Filed by Sientra, Inc.	02-13	CI
Sientra to Pursue Strategic Sale of Its Business Through Voluntary Chapter 11 Process	02-12	CI
Motion for Joint Administration Filed by Sientra, Inc.	02-12	CI
Sientra, Inc. Filed for Bankruptcy	02-12	CI
Stifel Adjusts Price Target on Sientra to $2 From $4, Maintains Buy Rating	11-13	MT
Transcript : Sientra, Inc., Q3 2023 Earnings Call, Nov 09, 2023	11-09
Earnings Flash (SIEN) SIENTRA Reports Q3 Revenue $19.5M	11-09	MT
Sientra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
North American Morning Briefing : Fed Decision, -2-	11-01	DJ
Craig-Hallum Downgrades Sientra to Hold From Buy, Cuts Price Target to $2 From $10	31/10/23	MT
Sientra, Inc. Provides Revenue Guidance for the Third Quarter of 2023	30/10/23	CI

Chart Sientra, Inc.

Duration

Period

More charts

Company Profile

Sientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.

Sector

Medical Equipment, Supplies & Distribution

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
SIENTRA, INC.	-94.26%	419K
ABBOTT LABORATORIES	-5.43%	181B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.29B
DEXCOM, INC.	+5.86%	52.24B
CENCORA, INC.	+8.15%	44.3B
HOYA CORPORATION	+6.67%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.52B
TERUMO CORPORATION	+20.03%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.91B

Other Medical Equipment, Supplies & Distribution

Sientra, Inc.

Equities

SIEN

US82621J2042

Medical Equipment, Supplies & Distribution

Sientra, Inc. Appoints Andy Schmidt as Chief Financial Officer

Latest news about Sientra, Inc.

Chart Sientra, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution